Core for Life - a new European alliance in biomedical research: http://t.co/Hvv6P88kRt
FlandersBio informs you about important regional and national life sciences news. Send us your news. If your news is of interest to the life sciences community, we will post it on our website.
FlandersBio informeert u over belangrijk nieuws op het vlak van de biowetenschappen. Bezorg ons jouw nieuwtjes. Als het interessant is voor de sector, zullen wij het op onze website plaatsen.
Multiplicom, a molecular diagnostics company specializing in innovative molecular genetics tests based on massive parallel sequencing, has received CE/IVD mark accreditation for its first-in-class BRCA MASTR Dx test. The test identifies mutations in the coding regions of the BRCA 1&2 genes in individuals with increased risk for breast, ovarian and/or related cancers. read more
Cryo-Save becomes the first stem cell bank operating in India to receive the WHO-GMP certification. read more
FORMAC Pharmaceuticals N.V., a Belgian-based drug development company, is pleased to announce that the European Medicines Agency (EMA) has granted Orphan Drug Designation to FORMAC's FP110 on March 9, 2011. An orphan drug is a drug for a rare disease. read more
PharmaNeuroBoost NV (PNB) reported today that both the U.S. Patent and Trade Office (USPTO) and Japanese Patent Office (JPT) granted the patent application of its lead product PNB01, a fixed dose combination of citalopram and low dose pipamperone, as a pharmaceutical composition of matter, for treating a mood disorder or an anxiety disorder. read more
FUGEIA today announced that it has received the FDA No Objection Letter with regard to the GRAS (Generally Recognized As Safe) status of its Brana VitaTM wheat bran extract. read more